Tudor Investment Corp
CLVS

Tudor Investment Corp’s Clovis Oncology, Inc. CLVS Stock Holding History

Tudor Investment Corp’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,110
Closed -$22K – 2639
2022
Q1 		$22K Sell
11,110
-23,321
-68% -$45.8K ﹤0.01% 1900
2021
Q4 		$93K Buy
+34,431
New +$127K ﹤0.01% 2237
2021
Q3 		– Sell
-331,063
Closed -$1.92M – 2934
2021
Q2 		$1.92M Buy
331,063
+303,196
+1,088% +$1.78M 0.04% 580
2021
Q1 		$196K Buy
+27,867
New +$187K ﹤0.01% 1438
2020
Q3 		– Sell
-11,934
Closed -$81K – 1613
2020
Q2 		$81K Buy
+11,934
New +$90.4K ﹤0.01% 1094
2020
Q1 		– Sell
-66,634
Closed -$695K – 1411
2019
Q4 		$695K Buy
+66,634
New +$485K 0.03% 618
2019
Q3 		– Sell
-53,849
Closed -$801K – 1413
2019
Q2 		$801K Buy
+53,849
New +$973K 0.02% 571
2018
Q1 		– Sell
-5,868
Closed -$399K – 1320
2017
Q4 		$399K Buy
+5,868
New +$410K 0.01% 691
2016
Q2 		– Sell
-13,858
Closed -$266K – 2011
2016
Q1 		$266K Sell
13,858
-211,142
-94% -$4.47M 0.01% 1360
2015
Q4 		$7.88M Buy
225,000
+220,869
+5,347% +$14.2M 0.22% 69
2015
Q3 		$380K Buy
+4,131
New +$358K 0.01% 957

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Tudor Investment Corp's CLVS Position: Q2 2022 in Review

Tudor Investment Corp sold out of Clovis Oncology, Inc. (CLVS) in Q2 2022, closing a stake of 11,110 shares — an estimated $22K sold.

Tudor Investment Corp first reported a position in CLVS in Q3 2015 and held it in 11 quarters. The position peaked at $7.88M in Q4 2015. 115 funds tracked by Wall St. Rank hold CLVS as of Q2 2022.

  • Tudor Investment Corp reported no remaining Clovis Oncology, Inc. position as of Q2 2022 after selling out during the quarter.
  • Tudor Investment Corp sold 11,110 Clovis Oncology, Inc. shares in Q2 2022, an estimated $22K.
  • Tudor Investment Corp first reported a position in Clovis Oncology, Inc. in Q3 2015 and held it in 11 quarters.
  • Tudor Investment Corp's Clovis Oncology, Inc. position peaked at $7.88M in Q4 2015.
  • 115 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2022.

Based on Tudor Investment Corp's 13F filing for Q2 2022, filed 15 Aug 2022.